PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Vigabatrin
Presentation Product Chemical substance Chapter Items dispensed
Vigabatrin 500mg gran for soln sachets sugar free
0408010X0AAAFAF
Vigabatrin Vigabatrin Central Nervous System 2,288
Vigabatrin 500mg tablets
0408010X0AAAAAA
Vigabatrin Vigabatrin Central Nervous System 1,476
Sabril 500mg tablets
0408010X0BBAAAA
Sabril Vigabatrin Central Nervous System 200
Sabril 500mg granules for oral solution sachets
0408010X0BBABAF
Sabril Vigabatrin Central Nervous System 98
Vigabatrin 100mg soluble tablets sugar free
0408010X0AABLBL
Vigabatrin Vigabatrin Central Nervous System 10
Vigabatrin 500mg soluble tablets sugar free
0408010X0AABMBM
Vigabatrin Vigabatrin Central Nervous System 7
Vigabatrin 250mg/5ml oral solution
0408010X0AAATAT
Vigabatrin Vigabatrin Central Nervous System 3
Kigabeq 100mg soluble tablets
0408010X0BCAABL
Kigabeq Vigabatrin Central Nervous System No data available
Kigabeq 500mg soluble tablets
0408010X0BCABBM
Kigabeq Vigabatrin Central Nervous System No data available
Vigabatrin 100mg/5ml oral solution
0408010X0AAAUAU
Vigabatrin Vigabatrin Central Nervous System No data available
Vigabatrin 100mg/ml oral solution sugar free
0408010X0AABNBN
Vigabatrin Vigabatrin Central Nervous System No data available
Vigabatrin 350mg/5ml oral solution
0408010X0AABJBJ
Vigabatrin Vigabatrin Central Nervous System No data available
Vigabatrin 500mg/5ml oral solution
0408010X0AAAYAY
Vigabatrin Vigabatrin Central Nervous System No data available
Vigabatrin 700mg/5ml oral solution
0408010X0AABKBK
Vigabatrin Vigabatrin Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.